I am an interventional radiologist, a physician who uses x-ray, CT, ultrasound, and MR images to perform procedures less invasively. I am Chief of the Interventional Radiology Service in the Department of Radiology and also director of Memorial Sloan Kettering’s new Center for Image-Guided Intervention (CIGI). At CIGI, multiple imaging modalities and multiple disciplines will be combined to develop and apply new image-guided cancer therapies.
Interventional radiology is an increasingly common approach to treating cancer. We use images to see the tumor and the blood vessels that supply it, to help guide our minimally invasive tools to the site of the tumor, and to perform several different diagnostic and therapeutic techniques. Patients who undergo interventional radiological procedures do not need a large incision; they can often be “consciously sedated” rather than undergo general anesthesia, and in many cases their procedures are less risky and their recovery times shorter than they would be with traditional surgery.
My particular area of interest is treating tumors with thermal ablation — a technique in which we use imaging to guide a needle to a target tumor and then destroy it through the application of heat (radiofrequency ablation) or extreme cold (cryoablation). I treat kidney, liver, lung, and bone cancers with these procedures. I also perform hepatic artery embolization, a technique in which we inject particles into the main blood vessel that supplies a tumor to cut off its blood supply.
Some of my current research projects involve evaluating a new ablation tool called “irreversible electroporation” (NanoKnife); using a CT-guided clinical robot to perform procedures more accurately; using PET images to monitor the health of patients who have undergone ablation; and studying ways to boost the immune system’s reaction to cancer cells after tumor ablation.
- Clinical Expertise: Interventional Radiology: Tumor Ablation (radiofrequency ablation; cryoablation)
- Languages Spoken: English
- Education: MD, Yale School of Medicine
- Residencies: Yale-New Haven Hospital; The Johns Hopkins Hospital
- Board Certifications: Radiology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Led by Stephen B. Solomon
Clinical Trials Co-Investigated by Stephen B. Solomon
- A Phase I Study of Intratumoral Clostridium novyi-NT Spores in Patients with Persistent Solid Tumors
- A Phase Ib/II Study of Ad-RTS-hIL-12 and Veledimex for Locally Advanced or Metastatic Breast Cancer
- A Phase II Study of Pembrolizumab Immunotherapy plus Radiation Therapy or Ablation to Treat Metastatic Colorectal Cancer
- A Pilot Study of Erlotinib plus Local Treatment for Lung Adenocarcinoma that Has Spread to Multiple Sites
- A Pilot Study of Presurgical Immunotherapy with Nivolumab, Ipilimumab, and Cryoablation for Early-Stage Breast Cancer
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more